A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation
Status:
Completed
Trial end date:
2020-07-03
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label, randomized, propofol-controlled phase II clinical trial.A
total of ICU patients undergoing mechanical ventilation are intended to be enrolled and
randomly assigned to HSK3486 group and propofol group in a 2:1 ratio.
Phase:
Phase 2
Details
Lead Sponsor:
Sichuan Haisco Pharmaceutical Group Co., Ltd Sichuan Haisco Pharmaceutical Group Co., Ltd.